Showing 147,301 - 147,320 results of 228,003 for search '(( 5 ((wt decrease) OR (we decrease)) ) OR ( 10 ((ng decrease) OR (a decrease)) ))', query time: 2.35s Refine Results
  1. 147301

    Image_6_Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma.jpeg by Mona M. Al-Gizawiy (17787488)

    Published 2024
    “…</p>Results<p>In this study we demonstrate non-invasively, using longitudinal MRI surveillance, the potent antineoplastic effects of GaM in a novel rat xenograft model of trGBM, as evidenced by extended suppression of tumor growth (23.56 mm<sup>3</sup>/week untreated, 5.76 mm<sup>3</sup>/week treated, P < 0.001), a blunting of tumor perfusion, and a significant survival benefit (median overall survival: 30 days untreated, 56 days treated; P < 0.001). …”
  2. 147302

    Image_1_Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma.jpeg by Mona M. Al-Gizawiy (17787488)

    Published 2024
    “…</p>Results<p>In this study we demonstrate non-invasively, using longitudinal MRI surveillance, the potent antineoplastic effects of GaM in a novel rat xenograft model of trGBM, as evidenced by extended suppression of tumor growth (23.56 mm<sup>3</sup>/week untreated, 5.76 mm<sup>3</sup>/week treated, P < 0.001), a blunting of tumor perfusion, and a significant survival benefit (median overall survival: 30 days untreated, 56 days treated; P < 0.001). …”
  3. 147303

    Image_2_Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma.jpeg by Mona M. Al-Gizawiy (17787488)

    Published 2024
    “…</p>Results<p>In this study we demonstrate non-invasively, using longitudinal MRI surveillance, the potent antineoplastic effects of GaM in a novel rat xenograft model of trGBM, as evidenced by extended suppression of tumor growth (23.56 mm<sup>3</sup>/week untreated, 5.76 mm<sup>3</sup>/week treated, P < 0.001), a blunting of tumor perfusion, and a significant survival benefit (median overall survival: 30 days untreated, 56 days treated; P < 0.001). …”
  4. 147304

    Image_3_Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma.jpeg by Mona M. Al-Gizawiy (17787488)

    Published 2024
    “…</p>Results<p>In this study we demonstrate non-invasively, using longitudinal MRI surveillance, the potent antineoplastic effects of GaM in a novel rat xenograft model of trGBM, as evidenced by extended suppression of tumor growth (23.56 mm<sup>3</sup>/week untreated, 5.76 mm<sup>3</sup>/week treated, P < 0.001), a blunting of tumor perfusion, and a significant survival benefit (median overall survival: 30 days untreated, 56 days treated; P < 0.001). …”
  5. 147305

    Data_Sheet_1_Linking Multiscalar Fisheries Using Metacoupling Models.pdf by Andrew K. Carlson (8558910)

    Published 2020
    “…However, research approaches that consider human–nature interactions within as well as between adjacent and distant fisheries are scarce. As such, we measured and modeled marine fisheries catches at local and regional scales over 65 years (1950–2014), assessed cross-scalar interactions among fishing types (artisanal, subsistence, industrial, recreational), and predicted future catches using the metacoupling framework, a new approach for evaluating human-nature interactions within and across adjacent and distant fisheries (metacouplings). …”
  6. 147306

    Image_1_Everolimus in Invasive Malignant Renal Epithelioid Angiomyolipoma.pdf by Gang Guo (146383)

    Published 2021
    “…The objective response was assessed 3 months later, five partial response, two stable disease (SD), the mean greatest tumor diameter of all patients decreased from 9.6 to 5.2cm. …”
  7. 147307

    Supplementary Material for: Interdigitation and Ellipsoid Zones Disruption Correlate with Visual Outcomes among Treatment-Naive Patients with Diabetic Macular Edema by Sharef N. (10349900)

    Published 2021
    “…<b><i>Introduction:</i></b> We have recently shown that defects in interdigitation and ellipsoid zones (IZ and EZ) can predict response to anti-VEGF therapy in a small group of treatment-naive diabetic macular edema (DME) patients. …”
  8. 147308
  9. 147309
  10. 147310
  11. 147311
  12. 147312
  13. 147313
  14. 147314
  15. 147315
  16. 147316
  17. 147317
  18. 147318
  19. 147319
  20. 147320